A review of stereotactic body radiotherapy for the spine.


Journal

Physical and engineering sciences in medicine
ISSN: 2662-4737
Titre abrégé: Phys Eng Sci Med
Pays: Switzerland
ID NLM: 101760671

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 13 09 2019
accepted: 11 06 2020
pubmed: 27 6 2020
medline: 7 7 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Radiation therapy of the spine, as recourse for spinal tumours, is an effective method of achieving pain reduction and local control. Hypofractionated techniques like stereotactic body radiation therapy and especially stereotactic radiosurgery are quickly becoming more popular as studies are published demonstrating their superior outcomes. This review concerns aspects of spinal radiotherapy of interest to the clinical medical physicist, with a focus on stereotactic techniques. The literature surveyed is mostly from the last two decades, concentrating particularly on studies from the last few years. Clinical aspects of spinal disease are covered to give context to the development of different radiotherapy techniques and thus the changing suitability criteria of patients. The latest studies concerning the treatment pathway are reviewed and summarised-from simulation and prescription to contouring, treatment planning and treatment delivery. This then leads into a discussion of the accuracy and uncertainties surrounding different methods of immobilisation and image guidance. Treatment planning algorithms and approaches are also reviewed. Finally, we survey the most recent outcomes and statistics concerning failures, toxicity, survivability and control rates. With careful consideration of the latest literature, patients suffering from spinal disease have a good chance of positive outcomes following radiotherapy.

Identifiants

pubmed: 32588201
doi: 10.1007/s13246-020-00889-w
pii: 10.1007/s13246-020-00889-w
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-824

Auteurs

James Rijken (J)

Icon Cancer Centre, 480 Specialist Centre, Windsor Gardens, SA, Australia. james.rijken@icon.team.
Queensland University of Technology, Brisbane, QLD, Australia. james.rijken@icon.team.

Scott Crowe (S)

Queensland University of Technology, Brisbane, QLD, Australia.
Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Jamie Trapp (J)

Queensland University of Technology, Brisbane, QLD, Australia.

Tanya Kairn (T)

Queensland University of Technology, Brisbane, QLD, Australia.
Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH